Baron Financial Group’s CorMedix CRMD Stock Holding History

Baron Financial Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,000	Closed	-$4.02K	–	81
2022 Q2	$4.02K	Hold	1,000	–	–	﹤0.01%	175
2022 Q1	$5.48K	Hold	1,000	–	–	﹤0.01%	181
2021 Q4	$4.55K	Hold	1,000	–	–	﹤0.01%	189
2021 Q3	$4.65K	Hold	1,000	–	–	﹤0.01%	194
2021 Q2	$6.86K	Hold	1,000	–	–	﹤0.01%	188
2021 Q1	$9.99K	Hold	1,000	–	–	0.01%	172
2020 Q4	$7.43K	Hold	1,000	–	–	0.01%	187
2020 Q3	$6.03K	Buy	+1,000	New	+$5.02K	0.01%	194

Other funds holding CRMD

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baron Financial Group's CRMD Position: Q3 2022 in Review

Baron Financial Group sold out of CorMedix (CRMD) in Q3 2022, closing a stake of 1,000 shares — an estimated $4.02K sold.

Baron Financial Group first reported a position in CRMD in Q3 2020 and held it in 8 quarters. The position peaked at $9.99K in Q1 2021. 73 funds tracked by Wall St. Rank hold CRMD as of Q3 2022.

Baron Financial Group reported no remaining CorMedix position as of Q3 2022 after selling out during the quarter.
Baron Financial Group sold 1,000 CorMedix shares in Q3 2022, an estimated $4.02K.
Baron Financial Group first reported a position in CorMedix in Q3 2020 and held it in 8 quarters.
Baron Financial Group's CorMedix position peaked at $9.99K in Q1 2021.
73 funds tracked by Wall St. Rank held CorMedix as of Q3 2022.

Based on Baron Financial Group's 13F filing for Q3 2022, filed 3 Nov 2022.